CVE-2011-1284

Description

Integer overflow in the Client/Server Run-time Subsystem (aka CSRSS) in the Win32 subsystem in Microsoft Windows XP SP2 and SP3, Windows Server 2003 SP2, Windows Vista SP1 and SP2, Windows Server 2008 Gold, SP2, R2, and R2 SP1, and Windows 7 Gold and SP1 allows local users to gain privileges or cause a denial of service (memory corruption) via a crafted application that triggers an incorrect memory assignment for a user transaction, aka "CSRSS Local EOP SrvWriteConsoleOutput Vulnerability."

Category

7.2
CVSS
Severity: High
CVSS 2.0 •
EPSS 1.18% Top 25%
Vendor Advisory microsoft.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.us-cert.gov/cas/techalerts/TA11-193A.html third party advisory us government resource
https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A12734 vdb entry signature
https://docs.microsoft.com/en-us/security-updates/securitybulletins/2011/ms11-056 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2011-1284?
CVE-2011-1284 has been scored as a high severity vulnerability.
How to fix CVE-2011-1284?
To fix CVE-2011-1284, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2011-1284 being actively exploited in the wild?
It is possible that CVE-2011-1284 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.